Real-time enrollment status for this acute coronary syndrome clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 4:30 PM UTC
| NCT Number | NCT05918861 |
| Recruiting Status | Recruiting |
| Condition | Acute Coronary Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 2,000 participants |
| Active Locations | 186 sites in the US |
| Sponsor | DalCor Pharmaceuticals |
| Last Updated on CT.gov | June 22, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT05918861 is currently recruiting participants. This phase3 study for acute coronary syndrome is actively seeking new participants at 186 locations across the United States. The study is sponsored by DalCor Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05918861 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 186 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05918861 was last updated 3 weeks ago (June 22, 2026). HelloStudys verifies this status automatically.